EP1799675A4 - Procede de preparation de zolmitriptane de purete optique - Google Patents

Procede de preparation de zolmitriptane de purete optique

Info

Publication number
EP1799675A4
EP1799675A4 EP05738703A EP05738703A EP1799675A4 EP 1799675 A4 EP1799675 A4 EP 1799675A4 EP 05738703 A EP05738703 A EP 05738703A EP 05738703 A EP05738703 A EP 05738703A EP 1799675 A4 EP1799675 A4 EP 1799675A4
Authority
EP
European Patent Office
Prior art keywords
optically pure
preparing optically
zolmitriptan
pure zolmitriptan
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05738703A
Other languages
German (de)
English (en)
Other versions
EP1799675A1 (fr
Inventor
Islam Aminul
Bhar Chandan
K Sahadev
Vivekananda Reddy Mothukuri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Original Assignee
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd, Dr Reddys Laboratories Inc filed Critical Dr Reddys Laboratories Ltd
Publication of EP1799675A1 publication Critical patent/EP1799675A1/fr
Publication of EP1799675A4 publication Critical patent/EP1799675A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
EP05738703A 2004-04-22 2005-04-21 Procede de preparation de zolmitriptane de purete optique Withdrawn EP1799675A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN368CH2004 2004-04-22
US60416604P 2004-08-24 2004-08-24
PCT/US2005/013593 WO2005105792A1 (fr) 2004-04-22 2005-04-21 Procede de preparation de zolmitriptane de purete optique

Publications (2)

Publication Number Publication Date
EP1799675A1 EP1799675A1 (fr) 2007-06-27
EP1799675A4 true EP1799675A4 (fr) 2010-04-28

Family

ID=35241612

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05738703A Withdrawn EP1799675A4 (fr) 2004-04-22 2005-04-21 Procede de preparation de zolmitriptane de purete optique

Country Status (2)

Country Link
EP (1) EP1799675A4 (fr)
WO (1) WO2005105792A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006055964A2 (fr) * 2004-11-19 2006-05-26 Teva Pharmaceutical Industries Ltd. Formes cristallines de zolmitriptan
CZ2007158A3 (cs) * 2007-02-26 2008-10-22 Zentiva, A. S. Zpusob prípravy zolmitriptanu
CN103275075B (zh) * 2013-06-24 2015-01-07 成都天台山制药有限公司 佐米曲普坦及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014901A1 (fr) * 2002-08-07 2004-02-19 Vita Cientifica, S.L. Procede d'elaboration de composes de zolmitriptan

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9516143D0 (en) * 1995-08-07 1995-10-04 Wellcome Found Improved chemical synthesis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014901A1 (fr) * 2002-08-07 2004-02-19 Vita Cientifica, S.L. Procede d'elaboration de composes de zolmitriptan

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MOLONEY, GERARD P. ET AL: "A Novel Series of 2,5-Substituted Tryptamine Derivatives as Vascular 5HT1B/1D Receptor Antagonists", JOURNAL OF MEDICINAL CHEMISTRY , 40(15), 2347-2362 CODEN: JMCMAR; ISSN: 0022-2623, 1997, XP002260072 *
See also references of WO2005105792A1 *

Also Published As

Publication number Publication date
EP1799675A1 (fr) 2007-06-27
WO2005105792A1 (fr) 2005-11-10

Similar Documents

Publication Publication Date Title
EP1828170A4 (fr) Procede de preparation de voriconazole
ZA200704535B (en) Process for preparing rosuvastatin
GB0416001D0 (en) Process
GB0407329D0 (en) Process
GB0404793D0 (en) Process
EP1751123A4 (fr) Processus pour préparer de l'irbésartan
GB0413053D0 (en) Process
GB0414847D0 (en) Process
EP1721871A4 (fr) Proc d de production de biogaz
EP1719740A4 (fr) Procede de production de dispositif optique
GB0406894D0 (en) Process
GB0410289D0 (en) Process
EP1799675A4 (fr) Procede de preparation de zolmitriptane de purete optique
GB0416694D0 (en) Process for preparing microcrystals
EP1754738A4 (fr) Processus de production de polypyridinium
GB0412875D0 (en) Process
GB0414335D0 (en) Process
IL182058A0 (en) Process for preparing ziprasidone
GB0418791D0 (en) Novel process
IL183804A0 (en) Process for preparing substituted 2-alkoxycarbonyl-3-aminothiophenes
IL181075A0 (en) Process for producing 2-(4-methyl-2-phenylpiperazine-1-yl)-3-cyanopiridine
GB0411583D0 (en) Process
GB0411185D0 (en) Process
GB0401540D0 (en) Process
GB0413084D0 (en) Process

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20061115

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20100329

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100626